Prognostic impact of the 21-gene recurrence score in patients presenting with stage IV breast cancer.
Tari A. King
Research Funding - Genomic Health
Jaclyn P Lyman
Research Funding - Genomic Health
Mithat Gonen
No relevant relationships to disclose
Amy Voci
No relevant relationships to disclose
Marina De Brot
No relevant relationships to disclose
Camilla Boafa
No relevant relationships to disclose
Amy Pratt Sing
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Eun-Sil Shelley Hwang
Consultant or Advisory Role - Genomic Health
Michael Alvarado
Consultant or Advisory Role - Genomic Health
Minetta C. Liu
No relevant relationships to disclose
Judy Caroline Boughey
No relevant relationships to disclose
Kandace P. McGuire
No relevant relationships to disclose
Catherine H. Van Poznak
Employment or Leadership Position - Bone and Cancer Foundation; Paget Foundation
Research Funding - NIH - NIDCR; Translational Breast Cancer Research Consortium
Other Remuneration - NCCN (Educational Presentation Development); School of Breast Oncology (Educational Presentation Development); UpToDate (Intellectual Property Interests); Western Michigan University School of Medicine (Educational Presentation Development)
Lisa K. Jacobs
No relevant relationships to disclose
Ingrid M. Meszoely
No relevant relationships to disclose
Helen Krontiras
No relevant relationships to disclose
Gildy Babiera
No relevant relationships to disclose
Larry Norton
No relevant relationships to disclose
Monica Morrow
No relevant relationships to disclose
Clifford Hudis
Research Funding - Merck
Other Remuneration - Estee Lauder Company (I)